Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis buys sickle cell player Selexys in $665M deal
Novartis buys sickle cell player Selexys in $665M deal
Novartis buys sickle cell player Selexys in $665M deal
Submitted by
admin
on November 21, 2016 - 11:34am
Source:
Fierce Biotech
News Tags:
Novartis
Selexys
M&A
sickle cell disease
Headline:
Novartis buys sickle cell player Selexys in $665M deal
Do Not Allow Advertisers to Use My Personal information
